Literature DB >> 12444759

Visible light induced photocleavage of DNA by a mixed-metal supramolecular complex: [[(bpy)(2)Ru(dpp)](2)RhCl2]5+.

Shawn Swavey1, Karen J Brewer.   

Abstract

The mixed-metal supramolecular complex, [[(bpy)(2)Ru(dpp)](2)RhCl(2)](PF(6))(5) (bpy = 2,2'-bipyridine and dpp = 2,3-bis(2-pyridyl)pyrazine) coupling two ruthenium light absorbers (LAs) to a central rhodium, has been shown to photocleave DNA. This system possesses a lowest lying metal to metal charge transfer (MMCT) excited state in contrast to the metal to ligand charge transfer states (MLCT) of the bpm and Ir analogues. The systems with an MLCT excited state do not photocleavage DNA. [[(bpy)(2)Ru(dpp)](2)RhCl(2)](PF(6))(5) is the first supramolecular system shown to cleave DNA. It functions through an excited state previously unexplored for this reactivity, a Ru --> Rh MMCT excited state. This system functions when irradiated with low energy visible light with or without molecular oxygen.

Entities:  

Year:  2002        PMID: 12444759     DOI: 10.1021/ic0257726

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  7 in total

1.  Control and utilization of ruthenium and rhodium metal complex excited states for photoactivated cancer therapy.

Authors:  Jessica D Knoll; Claudia Turro
Journal:  Coord Chem Rev       Date:  2015-01-01       Impact factor: 22.315

2.  Dual Photoreactivity of a New Rh2(II,II) Complex for Biological Applications.

Authors:  Regina N Akhimie; Jessica K White; Claudia Turro
Journal:  Inorganica Chim Acta       Date:  2016-04-18       Impact factor: 2.545

3.  Interaction with a Biomolecule Facilitates the Formation of the Function-Determining Long-Lived Triplet State in a Ruthenium Complex for Photodynamic Therapy.

Authors:  Avinash Chettri; Houston D Cole; John A Roque Iii; Kilian R A Schneider; Tingxiang Yang; Colin G Cameron; Sherri A McFarland; Benjamin Dietzek-Ivanšić
Journal:  J Phys Chem A       Date:  2022-02-18       Impact factor: 2.781

4.  Combined arene ruthenium porphyrins as chemotherapeutics and photosensitizers for cancer therapy.

Authors:  Frédéric Schmitt; Padavattan Govindaswamy; Olivier Zava; Georg Süss-Fink; Lucienne Juillerat-Jeanneret; Bruno Therrien
Journal:  J Biol Inorg Chem       Date:  2008-09-23       Impact factor: 3.358

5.  Selective Photodissociation of Acetonitrile Ligands in Ruthenium Polypyridyl Complexes Studied by Density Functional Theory.

Authors:  Yi-Jung Tu; Shivnath Mazumder; John F Endicott; Claudia Turro; Jeremy J Kodanko; H Bernhard Schlegel
Journal:  Inorg Chem       Date:  2015-08-05       Impact factor: 5.165

6.  Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433.

Authors:  Susan Monro; Katsuya L Colón; Huimin Yin; John Roque; Prathyusha Konda; Shashi Gujar; Randolph P Thummel; Lothar Lilge; Colin G Cameron; Sherri A McFarland
Journal:  Chem Rev       Date:  2018-10-08       Impact factor: 60.622

7.  Combination of Ru(ii) complexes and light: new frontiers in cancer therapy.

Authors:  Cristina Mari; Vanessa Pierroz; Stefano Ferrari; Gilles Gasser
Journal:  Chem Sci       Date:  2015-01-13       Impact factor: 9.825

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.